Lake Hiawatha, NJ, United States of America

Yanning Lin

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wyeth. Active years: 2019-2021.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yanning Lin: Innovator in Pharmaceutical Compositions

Introduction

Yanning Lin is a notable inventor based in Lake Hiawatha, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release dosage formulations. With a total of 3 patents to her name, her work has the potential to improve patient outcomes and reduce side effects associated with medication.

Latest Patents

Yanning Lin's latest patents focus on sustained release pharmaceutical compositions. These inventions provide controlled release dosage formulations of compounds, specifically aplindore, or pharmaceutically acceptable salts thereof. The dosage forms are designed to minimize side effects from the administration of such compounds, showcasing her commitment to enhancing therapeutic efficacy.

Career Highlights

Yanning Lin is currently employed at Wyeth, a well-respected company in the pharmaceutical industry. Her role involves research and development, where she applies her expertise to create innovative solutions that address medical needs. Her contributions have been instrumental in advancing the company's product offerings.

Collaborations

Throughout her career, Yanning Lin has collaborated with talented individuals such as Eric Joel Benjamin and Kai Zhuang. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical technologies.

Conclusion

Yanning Lin's work in the field of pharmaceutical compositions exemplifies her dedication to innovation and improving patient care. Her patents and collaborations reflect her significant impact on the industry, making her a valuable asset to the field of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…